teva to buy cephalon for $6.8 billion
the deal for the biopharmaceutical company comes just weeks after cephalon rejected a $5.7 billion takeover bid from valeant pharmaceuticals.
http://feeds.nytimes.com/click.phdo?i=319ccbd4d67df72b3c673a05bdf38f3e
4819
02 May 2011 23:55:34
nyt
business